Armata Pharmaceuticals Inc (ARMP)
2.36
+0.05
(+2.16%)
USD |
NYAM |
Nov 01, 16:00
Armata Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.0313 |
| June 30, 2017 | 0.0615 |
| March 31, 2017 | 0.09 |
| December 31, 2016 | 0.0826 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2008 | 0.0354 |
| March 31, 2008 | 0.0257 |
| December 31, 2007 | 0.0207 |
| September 30, 2007 | 0.0242 |
| June 30, 2007 | 0.0706 |
| March 31, 2007 | 0.171 |
| December 31, 2006 | 0.3166 |
| September 30, 2006 | 5.524 |
| June 30, 2006 | 1.876 |
| March 31, 2006 | 0.2594 |
| December 31, 2005 | 0.2725 |
| September 30, 2005 | 0.2454 |
| June 30, 2005 | 0.275 |
| March 31, 2005 | 0.2463 |
| December 31, 2004 | 0.2272 |
| September 30, 2004 | 0.2517 |
| June 30, 2004 | 0.2542 |
| March 31, 2004 | 0.2316 |
| December 31, 2003 | 0.3739 |
| September 30, 2003 | 0.3186 |
| June 30, 2003 | 0.8394 |
| March 31, 2003 | 4.364 |
| December 31, 2002 | 3.696 |
| September 30, 2002 | 1.999 |
| June 30, 2002 | 1.838 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.4322 |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 0.7145 |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.7481 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 108.31M |
| Total Liabilities (Quarterly) | 154.41M |
| Shareholders Equity (Quarterly) | -46.10M |